149 related articles for article (PubMed ID: 8743532)
1. Aging abolishes the renal response to L-arginine infusion in essential hypertension.
Campo C; Lahera V; Garcia-Robles R; Cachofeiro V; Alcazar JM; Andres A; Rodicio JL; Ruilope LM
Kidney Int Suppl; 1996 Jun; 55():S126-8. PubMed ID: 8743532
[TBL] [Abstract][Full Text] [Related]
2. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
3. [Pressor, renal and endocrine effects of systemic infusion of L-arginine in hypertensive patients].
Dell'Omo G; Catapano G; Ebel M; Gazzano A; Ducci M; Del Chicca M; Clerico A; Pedrinelli R
Ann Ital Med Int; 1995; 10(2):107-12. PubMed ID: 7619649
[TBL] [Abstract][Full Text] [Related]
4. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
[TBL] [Abstract][Full Text] [Related]
5. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
[TBL] [Abstract][Full Text] [Related]
7. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine.
Rahman MM; Varghese Z; Fuller BJ; Moorhead JF
Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645
[TBL] [Abstract][Full Text] [Related]
8. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
[TBL] [Abstract][Full Text] [Related]
9. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
[TBL] [Abstract][Full Text] [Related]
10. Endothelial function in hypertension.
Mattei P; Virdis A; Ghiadoni L; Taddei S; Salvetti A
J Nephrol; 1997; 10(4):192-7. PubMed ID: 9377726
[TBL] [Abstract][Full Text] [Related]
11. The effect of chloroquine on renal function and vasopressin secretion: a nitric oxide-dependent effect.
Ahmed MH; Ashton N; Balment RJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):156-61. PubMed ID: 12490586
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of an acute NaCl load in chronic nitric oxide blockade-induced hypertensive rats.
Rodríguez-Pérez JC; Brenner BM
J Physiol Biochem; 1998 Sep; 54(3):127-33. PubMed ID: 10217208
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide, atrial natriuretic factor, and dynamic renal autoregulation.
Wang X; Salevsky FC; Cupples WA
Can J Physiol Pharmacol; 1999 Oct; 77(10):777-86. PubMed ID: 10588482
[TBL] [Abstract][Full Text] [Related]
14. Does L-arginine alter proteinuria and renal hemodynamics in patients with chronic glomerulonephritis and hypertension?
Wolf SC; Erley CM; Kenner S; Berger ED; Risler T
Clin Nephrol; 1995 Jan; 43 Suppl 1():S42-6. PubMed ID: 7781205
[TBL] [Abstract][Full Text] [Related]
15. Vascular and renal effects of dopamine during extracellular volume expansion: Role of nitric oxide pathway.
Costa MA; Elesgaray R; Loria A; Balaszczuk AM; Arranz C
Life Sci; 2006 Feb; 78(14):1543-9. PubMed ID: 16223511
[TBL] [Abstract][Full Text] [Related]
16. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
Artery; 1998; 23(1):1-9. PubMed ID: 10846613
[TBL] [Abstract][Full Text] [Related]
17. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects.
Schlaich MP; Parnell MM; Ahlers BA; Finch S; Marshall T; Zhang WZ; Kaye DM
Circulation; 2004 Dec; 110(24):3680-6. PubMed ID: 15569830
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.
Tozer GM; Prise VE; Chaplin DJ
Cancer Res; 1997 Mar; 57(5):948-55. PubMed ID: 9041200
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of L-arginine on insulin-mediated blood flow and glucose disposal in the elderly.
Meneilly GS; Battistini B; Floras JS
Metabolism; 2001 Feb; 50(2):194-9. PubMed ID: 11229429
[TBL] [Abstract][Full Text] [Related]
20. Role of glomerular nitric oxide in glycerol-induced acute renal failure.
Valdivielso JM; López-Novoa JM; Eleno N; Pérez Barriocanal F
Can J Physiol Pharmacol; 2000 Jun; 78(6):476-82. PubMed ID: 10914637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
